Markus Müschen, M.D., Ph.D., is the founding chair of the Department of Systems Biology within Beckman Research Institute, and holds the Norman and Sadie Lee Foundation Professorship in Pediatrics. Dr. Müschen is also the associate director of pediatric oncology of the comprehensive cancer center.
Dr. Müschen is a Howard Hughes Medical Institute Faculty Scholar and is supported by a National Cancer Institute Outstanding Investigator Award (R35). He received his medical degree from the Heinrich-Heine-Universität in Düsseldorf, Germany, where he graduated summa cum laude. He completed his medical training in hematology-oncology in Cologne, under Volker Diehl.
After scientific training at the Institute Pasteur in Paris, in Ralf Küppers’ and Klaus Rajewsky’s laboratory at the Institute of Genetics in Cologne and Janet Rowley’s laboratory at the University of Chicago, Dr. Müschen launched his laboratory in Cologne and moved with his entire group to the University of Southern California in 2005 as program leader, Hematological Malignancies Program, USC Norris Comprehensive Cancer Center and Children’s Hospital Los Angeles.
Dr. Müschen received a Scholar Award from the Leukemia & Lymphoma Society, a Stand Up to Cancer Innovation Award from the American Association for Cancer Research, a Senior Investigator Award from the Welcome Trust and held the 2012 Sir Alexander Haddow Professorship of the Institute of Cancer Research in London. From 2010 to 2017, Dr. Müschen was a tenured professor of Laboratory Medicine, Pathology and Medicine at the University of California San Francisco (UCSF) and served as program leader of the Hematological Malignancies Program of the UCSF Comprehensive Cancer Center.
Dr. Müschen and his colleagues have developed a comprehensive research program that will predict relapse of acute lymphoblastic leukemia (ALL) and a drug-discovery program that will help to prevent or overcome ALL relapse in children.
July 05, 2017